MIRA Pharmaceuticals, Inc. (MIRA) stock
MIRANasdaqPharmaceutical Preparations
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 6/30
$0.59−0.05 (-7.66%)
Close on Nov 18, 2026Market cap $24.84MP/E –Yield –
MIRA Pharmaceuticals ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
No ebitda figures for MIRA Pharmaceuticals
MIRA Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?